DTaP-IPV combination vaccine

BIOLOGICAL2 trials

Sponsors

Boryung Pharmaceutical Co., Ltd, Boryung Biopharma Co., Ltd.

Conditions

DiphtheriaPertussisPoliomyelitisTetanus

Phase 3

Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS

CompletedNCT02458183

Boryung Pharmaceutical Co., LtdDiphtheria, Pertussis, Poliomyelitis +1

Start: 2015-02-02End: 2018-05-05Updated: 2023-06-28

To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years

Boryung Biopharma Co., Ltd.Diphtheria, Pertussis, Poliomyelitis +1

Start: 2019-12-26End: 2021-07-30Target: 249Updated: 2020-11-06